The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Mitochondrial Biomarkers, 2018Studying Changes in Phosphatidylethanolamine as a New Marker of Parkinson's Disease
Study Rationale:
While most cases of Parkinson's disease (PD) have no known cause, some are caused by changes (mutations) in genes such as SNCA, which regulates the production of a protein called alpha... -
Research Grant, 2018Development of Experimental Setups Using New Antibodies to Detect Alpha-synuclein in Cerebrospinal Fluid
Study Rationale:
Research studies have yet to clearly explain whether alpha-synuclein oligomers -- clumps of protein alpha-synuclein -- in biologicals fluids can be used in clinics as measures of... -
Research Grant, 2018Evaluation and Comparison of Existing Tests for Alpha-synuclein
Study Rationale:
An increase in the levels of alpha-synuclein -- a sticky protein that clumps in the brains of people with Parkinson's disease (PD) -- has been directly linked to an increased risk of... -
Research Grant, 2018Assessing the Effects of the Glucosylceramide Lipid on Protein Clumping
Study Rationale:
Changes (mutations) in the GBA1 gene cause Gaucher disease, a rare condition that causes fatty substances to build up and organs to swell, and increase the risk of Parkinson's disease... -
Access to Data and Biospecimens, 2018A New Test for Rapid and Ultra-Sensitive Detection of Hallmarks of Parkinson's Disease in Cerebrospinal Fluid
Study Rationale:
The diagnosis and treatment of Parkinson's disease (PD) would be aided by the availability of direct and highly sensitive tests for the abnormal clumps of protein alpha-synuclein... -
Access to Data and Biospecimens, 2018Discovery and Verification of Parkinson's Disease Biomarkers
Study Rationale:
The identification, development and use of Parkinson's disease (PD) biomarkers -- objective measures of disease -- remains a priority for researchers searching for a cure. Using a...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.